FAM47A activators encompass a diverse array of chemical compounds that target various biochemical pathways, ultimately converging on the modulation of FAM47A activity. Certain activators operate by increasing intracellular concentrations of second messengers, such as cAMP, which subsequently activates protein kinase A (PKA). The activated PKA can phosphorylate substrates within the cell, including FAM47A, enhancing its functional interaction with other signaling entities. Other compounds achieve a similar outcome by inhibiting the breakdown of cAMP, thereby indirectly fostering PKA activity and the associated phosphorylation events that activate FAM47A. Additionally, some activators directly engage protein kinase C (PKC), a kinase that phosphorylates a plethora of proteins, which may encompass FAM47A, hence modulating its function within the cellular milieu.
The intracellular calcium concentration is another critical regulator of FAM47A activity, with specific activators functioning by raising these levels, thereby triggering calcium-dependent kinases that could phosphorylate and activate FAM47A. Ionophores that transport calcium across cell membranes contribute to this calcium influx, resulting in the activation of calcium-dependent signaling cascades that impinge upon FAM47A. Moreover, the inhibition of protein phosphatases leads to sustained phosphorylation states within the cell, which may result in the continued activation of FAM47A by preventing the removal of activating phosphate groups. Inhibition of specific kinases within major signaling pathways, such as the MAPK or PI3K/AKT pathways, has the potential to cause compensatory shifts that favor the activation of alternative pathways or proteins, including FAM47A, thereby ensuring cellular homeostasis.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, which increases cAMP levels by preventing its breakdown, indirectly enhancing the activation of PKA and subsequent phosphorylation of FAM47A. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC) which can phosphorylate target proteins, potentially including FAM47A, thereby altering its function and interaction with other cellular components. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium concentration, which can activate calcium-dependent kinases such as calmodulin-dependent kinase (CaMK), potentially leading to the phosphorylation and activation of FAM47A. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A calcium ionophore that raises intracellular calcium levels and activates calcium-dependent signaling pathways, which may lead to the activation of enzymes that can phosphorylate FAM47A. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A membrane-permeable cAMP analog that activates PKA, potentially leading to the phosphorylation and activation of FAM47A within its signaling cascade. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits protein phosphatases PP1 and PP2A, preventing dephosphorylation of proteins, which can result in the sustained activation of proteins phosphorylated by kinases, including FAM47A. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates MAPK pathways such as JNK and p38, which can lead to the activation of transcription factors and other downstream proteins that may influence FAM47A activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can alter downstream AKT signaling, potentially affecting the phosphorylation status and activity of FAM47A through altered signaling dynamics. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK1/2 leading to decreased activation of ERK1/2 in the MAPK pathway. This could result in compensatory signaling shifts that enhance the phosphorylation and activity of FAM47A. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
A cell-permeable calcium chelator that can modulate calcium signaling. By controlling calcium levels, it indirectly affects calcium-dependent kinases that may phosphorylate and activate FAM47A. | ||||||